|15th December 2020||Mark A Sirgo||230,769||Open or private purchase||$0.65||$149,999.85|
|15th December 2020||John Temperato||153,846||Open or private purchase||$0.65||$99,999.90|
|15th December 2020||Edward J Sitar||61,538||Open or private purchase||$0.65||$39,999.70|
|2nd December 2020||Israel Gp Ltd. Orbi Med||103,200||Open or private sale||$21.60||$2,229,120.00|
|27th November 2020||John Temperato||203,667||Grant/award etc.||$0.00|
|9th November 2020||Lorin K Johnson||4,262||Exercise of in-the-money or at-the-money derivatives securities (usually options)||$4.00||$17,048.00|
|30th October 2020||Israel Gp Ltd. Orbi Med||1,943,734||Other acquisition or disposition||$0.00|
|30th October 2020||Nissim Darvish||1,943,734||Other acquisition or disposition||$0.00|
|30th October 2020||Mark A Sirgo||4,513||Other acquisition or disposition||$0.00|
|30th October 2020||John Temperato||4,513||Other acquisition or disposition||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharm Pharmaceutical company. The company is founded by Jay P. Madan and Kendyle Woodard in 2012.